ETON ETON PHARMACEUTICALS INC
FollowCOMMON STOCK (common), issuer CIK 1710340
Filings received so far for Q3 2026: 7 13F filers report a position in ETON shares at 2026-09-30. The quarter is not complete: its 13F deadline is 2026-11-14, and the counts grow as filings arrive.
13D and 13G filers
No 13D or 13G on this security in the data. Structured 13D/G data starts 2024-12-18.
Insider trades
| Owner | Date | Shares | Price | Filing |
|---|---|---|---|---|
| Krempa Davidofficer (Chief Business Officer) | 2026-10-06 | -4,166 S | $55.0663 | Form 4 |
| Krempa Davidofficer (Chief Business Officer) | 2026-10-02 | +10,522 M | Form 4 |
13F holders, Q3 2026
Filers in the available 13F reports with a share position at 2026-09-30, filer groups collapsed to one row (method), largest first. Options and principal amounts are left out. A group row states no % of portfolio, since each member reports its own portfolio: the members' percents are listed under it. A value about 1,000 times or 1/1,000 of the price other filers imply is shown as filed but neither ranks the row nor enters a sum.
| Holder | Shares | Value | % of portfolio | Change | Source |
|---|---|---|---|---|---|
| JUNCTURE WEALTH STRATEGIES, LLC | 27,978 | $1.44M | 0.37% | -871 | 13F-HRTimeline |
| TOTH FINANCIAL ADVISORY CORP | 1,700 | $87.5K | 0.01% | +500 | 13F-HRTimeline |
| Farther Finance Advisors, LLC | 151 | $7.78K | <0.01% | +28 | 13F-HRTimeline |
| Byrne Asset Management LLC | 100 | $5.2K | <0.01% | new | 13F-HRTimeline |
| GAMMA Investing LLC | 92 | $4.74K | <0.01% | +71 | 13F-HRTimeline |
| Versant Capital Management, Inc | 73 | $3.76K | <0.01% | +12 | 13F-HRTimeline |
| MassMutual Private Wealth & Trust, FSB | 52 | $2.68K | <0.01% | 0 | 13F-HRTimeline |
Events
Krempa David acquired 6,356 ETON shares between 2026-10-02 and 2026-10-06, Form 4 filed 2026-10-06. 0001437749-26-032240
Accepted , ingested